NFKB2 and urinary bladder carcinoma: These results demonstrate that p100 exhibits an inhibitory effect on anchorage-independent growth and cell cycle progression accompanied with suppression of cyclin, further suggesting that p100 downregulation may contribute to human bladder cancer development.